A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MA / microalbuminuria

[Related PubMed/MEDLINE]
Total Number of Papers: 329
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MA  (>> Co-occurring Abbreviation)
Long Form:   microalbuminuria
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A new potential mode of cardiorenal protection of KLOTHO gene variability in type 1 diabetic adolescents. T1D, UA
2020 Early retinal neurodegeneration in preclinical diabetic retinopathy: a multifactorial investigation. DM, DR, HL, HT, RNFL, SD-OCT
2020 High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes. NA
2020 Increased epicardial adipose tissue thickness is associated with microalbuminuria in hypertensive patients with left ventricular hypertrophy. EAT, LVH
2020 Microalbuminuria assessment after thoracic surgery: Early identification of complication risks. ASA
2019 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria. DN, ERFD, T2D
2019 Detection of Lower Albuminuria Levels and Early Development of Diabetic Kidney Disease Using an Artificial Intelligence-Based Rule Extraction Approach. DKD, NA, NHANES, Re-RX, UACR
2019 Evaluation of the relationship between short-term glycemic control and netrin-1, a urinary proximal tubular injury marker in children with type 1 diabetes. BMI, DN, HbA1c, IQR, NA, T1D
2019 Frequency and Risk Factors of Kidney Alterations in Children and Adolescents who Are Overweight and Obese in a Primary Health-care Setting. BMI
10  2019 Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes. CKD
11  2019 Prevalence and correlates of microalbuminuria in Yemeni children with sickle cell disease. BP, SCD
12  2019 Serum cystatin C as an early marker of nephropathy among type 2 diabetics: A meta-analysis. CI, CN, CysC, DN, Mi, NO, SMD
13  2019 Target organ damage in newly detected hypertensive patients. HTN, LVH, TOD
14  2018 Angiotensin-converting enzyme-inhibitor therapy in adolescents with type 1 diabetes in a regional cohort: Auckland, New Zealand from 2006 to 2016. ACEI, HTN, T1DM
15  2018 Association of microalbuminuria with diabetes is stronger in people with prehypertension compared to those with ideal blood pressure. ---
16  2018 Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes. DN, EDC, ESRD, EVs, miRNAs, T1D
17  2018 Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria. CRP, FPG, HbA1c, ICAM-1, T2DM
18  2018 Metabolic Syndrome-Related Features in Controlled and Resistant Hypertensive Subjects. BP, LAR, MetS, RHTN
19  2018 Prevalence of Microalbuminuria in Adult Patients with Sickle Cell Disease in Eastern Saudi Arabia. ACR, BMI, JHAH, SCN
20  2018 Proteins of TNF-alpha and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria. T1D
21  2018 Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes. eGFR, IQR, RAS, sKlotho, T2DM
22  2018 Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis. FBG, hs-CRP, SBP, UA
23  2018 The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy. 3-NT, CA, DN, IL-6, insulin therapy, NA, SOD
24  2018 The prevalence of microalbuminuria and associated factors among patients with type 2 diabetes mellitus in Botswana. ACR, DM
25  2018 Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria. CAC, DN, eGFR, NT-proBNP, UAER
26  2017 A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. DL, HTN, NAFLD, PDC, T2D
27  2017 Biomarkers of diabetic nephropathy: A 2017 update. DKD, DN, UAE
28  2017 Blood pressure regulation determined by ambulatory blood pressure profiles in children and adolescents with type 1 diabetes mellitus: Impact on diabetic complications. ABPM, BP, BPV, DR, MAP, PP, SBP, SDS
29  2017 Clustering of cardio-metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuria. CIMT, FMD, PWV, T1D
30  2017 Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system. DN, MS, PCA, PLS-DA
31  2017 Education and hypertension: impact on global cardiovascular risk. MetS
32  2017 Hypertension is an important risk determinant for chronic kidney disease: results from a cross-sectional, observational study from a rural population in South India. CKD, eGFR, HTN
33  2017 Microalbuminuria is a late event in patients with hypertension: Do we need a lower threshold? IMT, LV
34  2017 Microalbuminuria Is Associated with Lower Weight and Taller Height in Adolescence. UACR
35  2017 Prevalence and associations of microalbuminuria in proteinuria-negative patients with type 2 diabetes in two regional hospitals in Cameroon: a cross-sectional study. SSA, UACR
36  2017 Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries. DM, DN
37  2017 Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa. BMI, LDL
38  2017 Relationship between blood pressure variability and target organ damage in elderly patients. BPV, d SBPV, IMT, LVMI, SBPV, TC
39  2017 Relationships of pancreatic beta-cell function with microalbuminuria and glomerular filtration rate in middle-aged and elderly population without type 2 diabetes mellitus: a Chinese community-based analysis. GFR, HOMA-beta, T2DM
40  2017 Serum obestatin and omentin levels in patients with diabetic nephropathy. NA
41  2017 Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy. AIT, GSD
42  2017 Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes - A comparative study of two markers to identify high risk patients. 8-oxoGuo, CVD
43  2016 Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time. SCD
44  2016 Exercise-induced albuminuria is related to metabolic syndrome. ACR, EiA, MS
45  2016 Predictive modeling using a nationally representative database to identify patients at risk of developing microalbuminuria. NHANES
46  2016 Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal. CV, HTN, MicralA, T2DM
47  2016 Screening for Nephropathy in Diabetes Mellitus: Is Micral-Test Valid among All Diabetics? MT, T2D
48  2016 X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage. GBM, XLAS
49  2016 [Prevalence of microalbuminuria in patients with diabetes mellitus in the Czech Republic: Project IDN-Micro]. PU
50  2015 Akt Links Insulin Signaling to Albumin Endocytosis in Proximal Tubule Epithelial Cells. Akt, AS160, DM, DN, T1D
51  2015 Associations of serum Magnesium levels with diabetes mellitus and diabetic complications. DM
52  2015 Comparison of the adherence to the american diabetes association guidelines of diabetes care in primary care and subspecialty clinics. BP, FP, IM
53  2015 Microalbuminuria and prediction of cardiovascular complications in patients with coronary artery disease and type 2 diabetes mellitus after CABG surgery. CABG, CAD, DM, RD
54  2015 Prevalence of diabetic nephropathy in Type 2 Diabetes Mellitus in rural communities of Guanajuato, Mexico. Effect after 6 months of Telmisartan treatment. DN, eGFR, HT, MDRD, T2DM
56  2014 A hybrid intelligent system for diagnosing microalbuminuria in type 2 diabetes patients without having to measure urinary albumin. ---
57  2014 Biomarkers in diabetic nephropathy: Present and future. DN
58  2014 Deregulation of adipokines related to target organ damage on resistant hypertension. BP, LVH, PWV, RHTN, TOD
59  2014 Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. GFR, NA, T1D
60  2014 Factors related to microalbuminuria in patients with chronic obstructive pulmonary disease. ABPM, COPD, CRP
61  2014 Is late-preterm birth a risk factor for hypertension in childhood? ABPM, GFR, SDS, UAE
62  2014 Microalbuminuria as a risk predictor in diabetes: the continuing saga. ---
63  2014 Microalbuminuria in untreated prehypertension and hypertension without diabetes. BNP, HT, preHT, SBP
64  2014 Serum myeloid-related protein 8/14 complex is associated with microalbuminuria in patients with type 2 diabetes. SBP
65  2014 Subclinical albuminuria is linked to gray matter atrophy in type 2 diabetes mellitus. DM, GM, MPRAGE, MRI, UACR
66  2014 The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats. ACEI, AGE, ROS
67  2014 The contribution of glycemic control to impaired growth during puberty in young people with type 1 diabetes and microalbuminuria. HbA1c, SDS, T1D
68  2013 A correlation between acute kidney injury and myonecrosis after scheduled percutaneous coronary intervention. ACR, CI-AKI, CM, cTns, PCI, PMN, sCr, URL
69  2013 Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration? CVD, UAE
70  2013 Assessment of carotid atherosclerosis in type 2 diabetes mellitus patients with microalbuminuria by high-frequency ultrasonography. FBG, IMT, UAER
71  2013 Calorimetric analysis of the plasma proteome: identification of type 1 diabetes patients with early renal function decline. DSC, ERFD, T1D
72  2013 Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension. GFR, MDRD, SCr, Scys
73  2013 Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry. ACEI, ACR, ARB, BP
74  2013 Microalbuminuria and hyperfiltration in subjects with nephro-urological disorders. ACR, ALB, FF, SK
75  2013 Microalbuminuria can predict the development of acute kidney injury in critically ill septic patients. ACR, AKI, ICU, LOS, OR
76  2013 Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals? CV, DM, IR, LVH, MetS, UAE
77  2013 Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease. BAI, eGFR, VAI, WC, WHR, WHtR
78  2013 The effect of metabolic and hormonal parameters on microalbuminuria in adolescents with type 1 diabetes mellitus. ACR, BMI, DHEAS, T1DM
79  2013 The relationship between serum fetuin-A, cystatin-C levels, and microalbuminuria in patients with metabolic syndrome. ---
80  2012 A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. DR, ORs, T2DM
81  2012 Ambulatory blood pressure monitoring in children and adolescents with type-1 diabetes mellitus and its relation to diabetic control and microalbuminuria. ABPM, BP, DM, HTN
82  2012 Arterial blood pressure, proteinuria, and renal histopathology in clinically healthy retired racing greyhounds. BP, RRG
83  2012 Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients. AASI, ACR, eGFR, PP
84  2012 Cardiorenal syndrome in hypertensive rats: microalbuminuria, inflammation and ventricular hypertrophy. BNP, CRP, CRS, IL-6, LVH, SBP, TNF-alpha
85  2012 Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patients. LDL, UACR
86  2012 Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional study. ACR, CI, Cr, DN, NA, OA, OR, T1DM
87  2012 Elevated admission microalbuminuria predicts poor myocardial blood flow and 6-month mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. AMI, NA, PCI, STEMI, TIMI, UAER
88  2012 Evaluation of microalbuminuria in relation to asymptomatic bacteruria in Nigerian patients with sickle cell anemia. ALB, ASB, ISC, SCA
89  2012 Left ventricular mass index as a predictor of new-onset microalbuminuria in hypertensive subjects: a prospective study. ACR, BP, LVMI
90  2012 Metabolic syndrome and microalbuminuria predict renal outcome in non-diabetic patients with primary hypertension: the MAGIC study. CKD, MS
91  2012 Microalbuminuria is associated with the severity of coronary artery disease independently of other cardiovascular risk factors. CAD
92  2012 Microalbuminuria: a potential prognostic marker for acute stroke. CRP, mRS
93  2012 Nocturnal hypertension and organ damage in dippers and nondippers. ABPMs, BP, IM, SBP
94  2012 Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. AUC
95  2012 Screening for Microalbuminuria in HIV-Positive Children in Enugu. HIVAN
96  2012 The independent relationship between creatinine clearance, microalbuminuria and circadian blood pressure levels in newly diagnosed essential hypertensive and type 2 diabetic patients. ABPMs, BP, GFR
97  2012 Urinary microalbumin as a risk factor for ischaemic stroke. BSMMU
98  2012 [Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients]. BMI, DN, FBS, LA, NA, SBP, UA, UAER
99  2012 [Echocardiographic associations with renal function in hypertensive individuals treated at primary care level]. AH, BSA, GFR, LV, LVH, RWT
100  2011 Accuracy of urine dipstick test for microalbuminuria in type 2 diabetes mellitus patients. UACR